Trial intelligence / Profile preview

EscharEx (EX-03) in Venous Leg Ulcers

NCT07692178Phase 2Not yet recruiting

Sponsor
MediWound
Start
Aug 2026
Primary completion
Aug 2028
01

Overview

A Phase 2 trial of EscharEx in venous leg ulcer (VLU), sponsored by MediWound. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

EscharEx
03

Conditions

venous leg ulcer (VLU)

Beyond the preview

Go deeper on NCT07692178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07692178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call